High fidelity reverse transcriptases and the uses thereof
AssigneeLife Technologies Corporation
InventorsRobert Potter, Kim Rosenthal
Life of this patent
Estimating the term…
Loading patent…
AssigneeLife Technologies Corporation
InventorsRobert Potter, Kim Rosenthal
Estimating the term…
The invention relates to reverse transcriptases which have increased fidelity (or reduced misincorporation rate) and/or terminal deoxynucleotidyl transferase activity. In particular, the invention relates to a method of making such reverse transcriptases by modifying or mutating specified positions in the reverse transcriptases. The invention also relates to nucleic acid molecules containing the genes encoding the reverse trancriptases of the invention, to host cells containing such nucleic acid molecules and to methods to make the reverse trancriptases using the host cells. The reverse transcriptases of the invention are particularly suited for nucleic acid synthesis, sequencing, amplification and cDNA synthesis.
An MMLV reverse transcriptase which has been modified or mutated to decrease or eliminate terminal deoxynucleotidyl transferase activity, the reverse transcriptase comprising a polymerase domain having RNA-dependent DNA polymerase activity and a substitution in the amino acid sequence of the wild type MMLV polymerase domain within SEQ ID NO:
Dependencies are inferred from the claim text.